AstraZeneca PLC announced today that Karen Knudsen will be proposed for election as a Non-Executive Director at the Company’s Annual General Meeting on 11 April 2025.

AstraZeneca PLC announced today that Karen Knudsen will be proposed for election as a Non-Executive Director at the Company’s Annual General Meeting on 11 April 2025.

Karen will become a member of the Science Committee and the Sustainability Committee if elected to the Board.

Previous
Previous

Paradigm Health Announces Dr. Karen E. Knudsen Appointed to Board of Directors

Next
Next

Exai Bio Appoints Oncology Leader and Former American Cancer Society CEO, Karen E. Knudsen, MBA, PhD